Filing Details

Accession Number:
0001179110-20-001375
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-02-10 16:34:55
Reporting Period:
2020-02-06
Accepted Time:
2020-02-10 16:34:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1651561 Tabula Rasa Healthcare Inc. TRHC Services-Business Services, Nec (7389) 465726437
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1685832 V Orsula Knowlton 228 Strawbridge Drive
Suite 100
Moorestown NJ 08057
President Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-02-06 4,881 $0.00 738,991 No 4 A Direct
Common Stock Acquisiton 2020-02-06 7,955 $0.00 756,932 No 4 A Indirect Held by spouse.
Common Stock Disposition 2020-02-07 5,939 $61.55 750,993 No 4 S Indirect Held by spouse.
Common Stock Disposition 2020-02-07 2,061 $62.25 748,932 No 4 S Indirect Held by spouse.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 A Indirect Held by spouse.
No 4 S Indirect Held by spouse.
No 4 S Indirect Held by spouse.
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 20,000 Indirect Held by trust for children.
Common Stock 20,000 Indirect Held by trust for children.
Footnotes
  1. Dr. Orsula Knowlton received a restricted stock award of 4,881 shares of the Company's common stock on February 6, 2020. Such common stock will vest in full on December 1, 2020.
  2. Dr. Calvin Knowlton received a restricted stock award of 7,955 shares of the Company's common stock on February 6, 2020. Such common stock will vest in full on December 1, 2020.
  3. This sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Calvin H. Knowlton on December 7, 2018, as amended.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $60.99 to $61.98, inclusive. The reporting person undertakes to provide to Tabula Rasa HealthCare, Inc., any security holder of Tabula Rasa HealthCare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnotes (4) and (5) to this Form 4.
  5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $62.03 to $62.52, inclusive.